Theriva Biologics, Inc. Logo

Theriva Biologics, Inc.

Clinical-stage company developing systemically delivered oncolytic virus therapies.

TOVX | US

Overview

Corporate Details

ISIN(s):
US87164U5083 (+1 more)
LEI:
Country:
United States of America
Address:
9605 MEDICAL CENTER DRIVE, 20850 ROCKVILLE

Description

Theriva Biologics, Inc. is a clinical-stage immuno-oncology company developing a new class of oncolytic virus therapeutics. The company's platform is engineered for systemic delivery to overcome the protective barrier surrounding solid tumors. These developmental therapies are designed to selectively replicate within and kill tumor cells, with the potential to enhance current standard-of-care treatments. Theriva's lead candidates are being advanced to address a range of difficult-to-treat cancers and diseases in areas of high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-03 17:00
424B5
English 132.8 KB
2025-12-03 01:15 English 5.3 KB
2025-11-12 17:11
DEFA14A
English 410.9 KB
2025-11-12 09:16
10-Q
English 1.7 MB
2025-11-12 09:10
FORM 8-K
English 120.3 KB
2025-11-10 19:03 English 228.0 KB
2025-11-10 17:33
DEF 14A
English 471.0 KB
2025-11-07 17:36
S-3
English 200.0 KB
2025-10-31 17:05
PRE 14A
English 471.0 KB
2025-10-29 17:57
FORM 8-K
English 98.5 KB
2025-10-29 17:53
424B5
English 693.8 KB
2025-10-24 17:26
FORM 8-K
English 86.4 KB
2025-10-24 17:25
424B5
English 366.1 KB
2025-10-23 22:27 English 9.0 KB
2025-10-21 11:04 English 10.7 KB

Automate Your Workflow. Get a real-time feed of all Theriva Biologics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Theriva Biologics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Theriva Biologics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.